We identified two pro-proliferative genes whose protein expression increased upon BCL2 inhibition, FGFR3 (log2ratio = 0.87, p-value = 2.00E-03) and MTOR (log2ratio = 0.53, p-value = 3.49E-02), which have well-known roles in cancer signaling, i.e., FGFR signaling, and mTOR signaling (Figure 3b). Here, BCL2 is linked to cancer.